Together, these studies suggest that targeting IKK-mediated NF-κB activation in resident stromal cells of the vascular wall (endothelial cells and SMCs) could prove beneficial for the treatment of atherosclerosis. The gene discussed is NFKB1; the disease is atherosclerosis.